A Multi-Reader Multi-Case Pivotal Trial

NCT ID: NCT02692209

Last Updated: 2020-07-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

298 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-12-31

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this pivotal reader study is to assess the comparative accuracy of Fujifilm FFDM plus DBT versus FFDM alone in the detection of breast cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The safety and effectiveness of FFDM + DBT are both linked to the ability of radiologists interpreting FFDM + DBT images to accurately diagnose breast cancer. Each study endpoint therefore addresses both safety and effectiveness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FFDM Plus DBT

FFDM Plus DBT images are being evaluated as compared to FFDM alone

FFDM Plus DBT

Intervention Type DEVICE

FFDM + DBT Images

FujiFilm Aspire Cristalle System

Full Field Digital Mammography

Fujifilm FFDM alone images are being evaluated as compared to FFDM + DBT

FFDM Alone

Intervention Type DEVICE

FFDM Alone Images

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FFDM Plus DBT

FFDM + DBT Images

FujiFilm Aspire Cristalle System

Intervention Type DEVICE

FFDM Alone

FFDM Alone Images

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Eligible subjects under protocol FMSU2013-004A, defined as female subjects with known true clinical status and with complete FFDM and DBT examinations, in which there is sufficient anatomical coverage, sufficient contrast, and no significant motion or other artifacts, as determined by the image-acquisition sites.

Exclusion Criteria

* Subjects who are in violation of protocol FMSU2013-004A.
* Subjects with unknown clinical status.
* Any subject whose positive mammogram was not read during the truthing process (see section 8) will not be considered for the pivotal MRMC reader study.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fujifilm Medical Systems USA, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert M Uzenoff

Role: STUDY_DIRECTOR

Fujifilm Medical Systems USA, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Scottsdale Medical Imaging, Ltd

Scottsdale, Arizona, United States

Site Status

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States

Site Status

Elizabeth Wende Breast Care, LLC (EWBC)

Rochester, New York, United States

Site Status

University of North Carolina - at Chapel Hill

Chapel Hill, North Carolina, United States

Site Status

University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FMSU2013-004G

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tomosynthesis Mammographic Imaging Screening Trial
NCT02616432 ACTIVE_NOT_RECRUITING NA